NeuroSense Therapeutics Other Current Assets

The latest other current assets for NRSN is $580K as of December 2025. That compares with $860K in the prior-year period — down 32.7% year over year. Investors often review this figure alongside NeuroSense Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, NRSN's other current assets moved from $860K to $580K — a 32.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeuroSense Therapeutics's operating scale or balance-sheet position.

A other current assets figure of $580K for NRSN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NRSN's other current assets ($580K), review year-over-year change from $860K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.